Trost Timothy W.

USNatural personCFO

Insider

Trost Timothy W.

USNatural personCFO

Transactions

Issuers

Buys / Sells

0/14

Last tx

02 Jan 2025

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
CHIMERIX INC	217,088	reported	22 May 2019	tx 65+971,727−217,420
Werewolf Therapeutics, Inc.	150,000	reported	02 Jan 2025	tx 7+831,686

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
02 Jan 2025	GRANT_AWARD	Werewolf Therapeutics, Inc.	150,000	0.00 USD	deriv
02 Jan 2025	GRANT_AWARD	Werewolf Therapeutics, Inc.	60,358	0.00 USD	deriv
02 Jan 2024	GRANT_AWARD	Werewolf Therapeutics, Inc.	150,000	0.00 USD	deriv
03 Jan 2023	GRANT_AWARD

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
CHIMERIX INC	217,088	reported	22 May 2019	tx 65+971,727−217,420
Werewolf Therapeutics, Inc.	150,000	reported	02 Jan 2025	tx 7+831,686

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
02 Jan 2025	GRANT_AWARD	Werewolf Therapeutics, Inc.	150,000	0.00 USD	deriv
02 Jan 2025	GRANT_AWARD	Werewolf Therapeutics, Inc.	60,358	0.00 USD	deriv
02 Jan 2024	GRANT_AWARD	Werewolf Therapeutics, Inc.	150,000	0.00 USD	deriv
03 Jan 2023	GRANT_AWARD